CARDIOVASCULAR JOURNAL OF AFRICA • Vol 22, No 1, January/February 2011
AFRICA
13
2. Higashi Y, Yoshizumi M. New methods to evaluate endothelial func-
tion: method for assessing endothelial function in humans using a
strain-gauge plethysmography: nitric oxide-dependent and -independent
vasodilation.
J Pharmacol Sci
2003;
93
(4): 399–404.
3. Maxwell AJ. Mechanisms of dysfunction of the nitric oxide pathway in
vascular diseases.
Nitric Oxide
2002;
6
(2): 101–124.
4. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular
injury: Part II: animal and human studies.
Circulation
2003;
108
(17):
2034–2040.
5. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for
the biological activity of endothelium-derived relaxing factor.
Nature
1987;
327
(6122): 524–526.
6. Sarr M, Chataigneau M, Etienne-Selloum N, Diallo AS, Schott C,
Geffard M,
et al
. Targeted and persistent effects of NO mediated by
S-nitrosation of tissue thiols in arteries with endothelial dysfunction
.
Nitric Oxide
2007;
17
(1): 1–9.
7. Sarr M, Chataigneau M, Martins S, Schott C, El Bedoui J, Oak MH,
et
al
. Red wine polyphenols prevent angiotensin II-induced hypertension
and endothelial dysfunction in rats: role of NADPH oxidase.
Cardiovasc
Res
2006;
71
(4): 794–802.
8. Sarr M, Lobysheva I, Diallo AS, Stoclet JC, Schini-Kerth VB, Muller
B. Formation of releasable NO stores by S-nitrosoglutathione in arter-
ies exhibiting tolerance to glyceryl-trinitrate.
Eur J Pharmacol
2005;
513
(1–2): 119–123.
9. Alencar JL, Lobysheva I, Chalupsky K, Geffard M, Nepveu F, Stoclet
JC, Muller B. S-nitrosating nitric oxide donors induce long-lasting inhi-
bition of contraction in isolated arteries.
J Pharmacol Exp Ther
2003;
307
(1): 152–159.
10. Marin J, Rodriguez-Martinez MA. Role of vascular nitric oxide in
physiological and pathological conditions.
Pharmacol Ther
1997;
75
(2):
111–134.
11. Megson IL, Webb DJ. Nitric oxide donor drugs: current status and future
trends.
Expert Opin Investig Drugs
2002;
11
(5): 587–601.
12. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular
agents modulating the bioactivity of nitric oxide: an overview.
Circ Res
2002;
90
(1): 21–28.
13. Alencar JL, Lobysheva I, Geffard M, Sarr M, Schott C, Schini-Kerth
VB,
et al
. Role of S-nitrosation of cysteine residues in long-lasting
inhibitory effect of nitric oxide on arterial tone.
Mol Pharmacol
2003;
63
(5): 1148–1158.
14. Alencar JL, Chalupsky K, Sarr M, Schini-Kerth V, Vanin AF, Stoclet
JC,
et al
. Inhibition of arterial contraction by dinitrosyl-iron complexes:
critical role of the thiol ligand in determining rate of nitric oxide (NO)
release and formation of releasable NO stores by S-nitrosation.
Biochem
Pharmacol
2003;
66
(12): 2365–2374.
15. Terluk MR, da Silva-Santos JE, Assreuy J. Involvement of soluble
guanylate cyclase and calcium-activated potassium channels in the long-
lasting hyporesponsiveness to phenylephrine induced by nitric oxide
in rat aorta.
Naunyn Schmiedebergs Arch
Pharmacol
2000;
361
(5):
477–483.
16. Megson IL, Chalupsky K, Sarr M, Schini-Kerth V, Vanin AF, Stoclet JC,
et al
. N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine:
chemical stability and prolonged nitric oxide mediated vasodilatation in
isolated rat femoral arteries.
Br J Pharmacol
1999;
126
(3): 639–648.
17. Megson IL, Greig IR, Gray GA, Webb DJ, Butler AR. Prolonged effect
of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat
femoral arteries: potential as a slow release nitric oxide donor drug.
Br J
Pharmacol
1997;
122
(8): 1617–1624.
18. Olson LJ, Knych ET, Jr, Herzig TC, Drewett JG. Selective guany-
lyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation.
Hypertension
1997;
9
(1 Pt 2): 254–261.
19. Hwang TL, Wu CC, Teng CM. Comparison of two soluble guanylyl
cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-
induced relaxation in guinea-pig trachea.
Br J Pharmacol
1998;
125
(6):
1158–1163.
20. Muller B, Kleschyov AL, Malblanc S, Stoclet JC. Nitric oxide-related
cyclic GMP-independent relaxing effect of N-acetylcysteine in lipopoly-
saccharide-treated rat aorta.
Br J Pharmacol
1998;
123
(6): 1221–1229.
21. Hussain AS, Marks GS, Brien JF, Nakatsu K. The soluble guany-
lyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one
(ODQ) inhibits relaxation of rabbit aortic rings induced by carbon
monoxide, nitric oxide, and glyceryl trinitrate.
Can J Physiol Pharmacol
1997;
75
(8): 1034–1037.
22. WangYX, Poon CI, Pang CC. Vascular pharmacodynamics of NG-nitro-
L-arginine methyl ester in vitro and in vivo.
J Pharmacol Exp Ther
1993;
267
(3): 1091–1099.
23. ReesDD, Palmer RM, SchulzR, HodsonHF,Moncada S. Characterization
of three inhibitors of endothelial nitric oxide synthase in vitro and in
vivo.
Br J Pharmacol
1990;
101
(3): 746–752.
24. Sayed N, Kim DD, Fioramonti X, Iwahashi T, Duran WN, Beuve A.
Nitroglycerin-induced S-nitrosylation and desensitization of soluble
guanylyl cyclase contribute to nitrate tolerance.
Circ Res
, 2008.
103
(6):
606–614.
25. Sayed N, Baskaran P, Ma X, van den Akker F, Beuve A. Desensitization
of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.
Proc
Natl Acad Sci USA
2007;
104
(30): 12312–12317.
26. Fernandes D, Assreuy J. Nitric oxide and vascular reactivity in sepsis.
Shock
2008;
30
(Suppl 1): 10–13.
27. Carrier GO, Fuchs LC, Winecoff AP, Giulumian AD, White RE.
Nitrovasodilators relax mesenteric microvessels by cGMP-induced
stimulation of Ca-activated K channels.
Am J Physiol
1997;
273
(1 Pt
2): H76–84.
28. Hansen PR, Olesen SP. Relaxation of rat resistance arteries by acetylcho-
line involves a dual mechanism: activation of K
+
channels and formation
of nitric oxide.
Pharmacol Toxicol
1997;
80
(6): 280–285.
29. Mistry DK, Garland CJ. Nitric oxide (NO)-induced activation of large
conductance Ca
2+
-dependent K
+
channels (BK(Ca)) in smooth muscle
cells isolated from the rat mesenteric artery.
Br J Pharmacol
1998;
124
(6): 1131–1140.
30. Batenburg WW, de Vries R, Saxena PR, Danser AH. L-S-nitrosothiols:
endothelium-derived hyperpolarizing factors in porcine coronary arter-
ies?
J Hypertens
2004;
22
(10): 1927–1936.
